Reimbursement diligence for medtech and life sciences investors

The Vantage pipeline rendered for investors, with risk-rated coding, coverage, and payment findings framed as deal questions and delivered in under a week.

Product
Vantage Diligence
Price
$7,500, flat
Timeline
Under a week

Reimbursement risk, answered inside a deal timeline

Reimbursement is the risk that kills medtech returns, and it is the one most diligence processes wave at with a paragraph. Vantage Diligence is the full landscape pipeline rendered for an investment decision, with risk-rated findings on coding, coverage, and payment framed as the deal questions they raise and delivered in under a week.

Large firms serve this market at big-transaction scale and price. Fast, fixed-price reimbursement diligence at seed through Series B check sizes was hard to buy until now. An expert who has sat on the company side of these decisions grades each risk, so the findings carry judgment about what is priced in and what is not.

What lands in the data room

  • Risk-rated reimbursement assessment across coding, coverage, and payment, each graded with the evidence shown
  • Deal-question framing that tells you what to ask management, what to verify, and what to price into terms
  • Timeline realism check on the company's own reimbursement claims
  • The verified ledger, so your team can audit any finding to its source
  • Expert risk grading that separates findings routine for the stage from those that should move terms

Anyone pricing reimbursement risk

Venture and seed funds

A fixed-price line item that fits pre-Series B check sizes and closes inside your diligence window.

Family offices and angels

Institutional-grade reimbursement diligence without an institutional retainer.

Strategics and corp dev

An independent read on a target's access story before the term sheet hardens it into valuation.

Asked and answered

Can you really deliver in under a week?

Yes, because the research fan-out is parallel and automated. The verification pass is the schedule's floor, and we do not skip it for speed. If a scope cannot be verified inside the window, we say so before signature.

Will the target company know?

The build runs on public and licensed sources; it requires nothing from the target. If you want management's data included, that becomes a scoped variant.

What if you find nothing alarming?

Then you get a clean, cited basis for conviction, which is worth as much as a red flag. The deliverable grades risk honestly in both directions.

Ready to scope it?

Thirty minutes fixes the question, the deliverable, and the price. Kickoff within days of signature.